breath-based diagnostics
Gemelli Biotech Raises $19M in Series A Round
The company will use the financing to accelerate the commercialization of its Trio-Smart and IBS-Smart diagnostic tests.
The company's breath test uses mass spectrometry to determine a user's response to the presence of SARS-CoV-2.
Gates Foundation Gifts Cardea Bio $1.1M to Develop Infectious Disease Breath Tests
The project is intended to demonstrate the feasibility of Cardea's biosignal processing unit test to detect odors for the diagnosis of infectious diseases.
FDA Grants First Emergency Use Authorization for Breath-Based COVID-19 Test
InspectIR Systems' test uses GC-MS to detect volatile organic compounds in an individual's breath associated with SARS-CoV-2 infection.
Finland-Based Deep Sensing Algorithms Works to Commercialize COVID-19 Breath Test After CE Marking
Premium
The firm's DSA BreathPass device measures a pattern of metabolic signatures found in a user's breath to determine the presence of SARS-CoV-2.
Nov 15, 2021
Nov 9, 2021
Jun 16, 2021
Dec 14, 2020
Imec Preparing Breath Test for SARS-CoV-2
Sep 19, 2019